Capture of circulating tumor cells from whole blood of prostate cancer patients using geometrically enhanced differential immunocapture (GEDI) and a prostate-specific antibody Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Immobilized
  • Immunoassay
  • Microfluidic Analytical Techniques
  • Neoplastic Cells, Circulating
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Geometrically enhanced differential immunocapture (GEDI) and an antibody for prostate-specific membrane antigen (PSMA) are used for high-efficiency and high-purity capture of prostate circulating tumor cells from peripheral whole blood samples of castrate-resistant prostate cancer patients.

publication date

  • January 7, 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3031459

Digital Object Identifier (DOI)

  • 10.1039/b917959c

PubMed ID

  • 20024046

Additional Document Info

start page

  • 27

end page

  • 9

volume

  • 10

number

  • 1